ABM Respiratory Care Announces the FDA Clearance of the BiWaze Clear System

ABM Respiratory Care, a leading medical technology company, is excited to announce the U.S. Food and Drug Administration’s 510(k) clearance of its groundbreaking BiWaze® Clear System. This revolutionary airway clearance system helps patients clear their airways and prevent or treat atelectasis while utilizing Oscillating Lung Expansion (OLE) therapy. The BiWaze® Clear System can be used to treat both acute and chronic respiratory conditions in hospitals, long-term care facilities, and the comfort of home.

OLE therapy is an innovative treatment that can help people with respiratory conditions like cystic fibrosis, bronchiectasis and neuromuscular conditions to clear their airways. This type of therapy has been used in hospitals for over a decade, and studies have shown that its effectiveness can help reduce postoperative pulmonary complications by as much as 31%, while also reducing the mean length of stay in the hospital by 1.6 days. It’s a powerful tool that can help patients stay healthier, faster.

The revolutionary BiWaze® Clear system is designed with convenience in mind; its lightweight, battery-powered design makes it the perfect traveling companion. The Dual Lumen Breathing Circuit™ ensures that exhaled aerosols remain trapped until they are filtered by a coaxial bacterial/viral filter. BiWaze® Clear is capable of delivering three therapies – lung expansion, high frequency oscillation and nebulization with the Aerogen® Solo – ensuring unparalleled comfort and care.

ABM Respiratory Care is proud to introduce an innovative OLE therapy system, the BiWaze Clear System, to help prevent the spread of bacterial and viral infections like COVID-19. According to the company’s CEO, Vinay Joshi, the new product is part of their expanding portfolio of respiratory care products and will assist in providing greater care to those in need.

About ABM Respiratory Care

ABM Respiratory Care is pioneering the future of respiratory therapy. Since 2017, we have been committed to providing intelligent, clinically differentiated, and innovative solutions to help people breathe better in any care setting. Our connected platform offers deeper breathing, improved oxygen exchange, and reduced exposure to aerosol emissions, offering a comprehensive approach to disease management for people with compromised respiratory systems. By advancing patient care, we are transforming the way respiratory therapy is delivered worldwide.

Leave a Comment